Clinical Outcomes of Transconjunctival Vs Transcutaneous Approaches in Orbital Fracture Repair
Vs: versus
1 other identifier
interventional
75
1 country
1
Brief Summary
Open reduction and internal fixation of zygomaticomaxillary complex (ZMC) fractures has a challenging impact on the selection of the suitable surgical approach to the orbital and zygomatic skeleton. Precise repair of the ZMC fractures needs a quite understanding of the regional anatomy, precise diagnosis, an accessible exposure, and an accurate rigid fixation of fracture to restore the normal form. The aesthetic results are one of the most important requirements for these incisions in facial fracture reduction. Conventional approaches to the infraorbital rim/orbital floor include transcutaneous as subciliary, subtarsal and infraorbital incisions and transconjunctival incision. A thorough understanding of each incisional technique requires an appreciation of the relevant anatomy putting in considerations the risk of associated complications. Aim of this study:To compare between transconjunctival approach and transcutaneous approaches in open reduction of zygomaticomaxillary fracture. Materials and methods: A study will be made on 75 patients who will undergo fracture repair of the zygomaticomaxillary complex. Twenty five of them (group A) will be treated via a subtarsal approach while. Other Twenty five patients (group B) via a transconjunctival approach. The remaining Twenty five patients (Group C) will be treated via infraorbital appeoach. Postoperative patient evaluation will be performed with specific attention paid towards, accessibility, the exposure duration (time from incision till exposure of the field), esthetic appearance ,postoperative pain, postoperative edema , wound healing, scaring, infection and postoperative ocular complications such as ectropion, entropion, scleral show and corneal abrasion. Postoperatively clinical examination along with radiographic examination will be done to evaluate the position of the zygoma and determine the adequacy of fracture reduction. Results: will be statistically analyzed using the IBM Statistical Package for Social Science (SPSS) software version 22.0
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 25, 2026
CompletedFirst Submitted
Initial submission to the registry
July 29, 2026
CompletedFirst Posted
Study publicly available on registry
August 12, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 25, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 25, 2026
August 12, 2026
August 1, 2026
6 months
July 29, 2026
August 6, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
operation time
starting from the skin incision till the reduction and fixation of the orbital rim
intraopertive in minutes
accessibility
objective assessment by the main surgeon ( mild, moderate, excellent) accessibility
intraopertive
Secondary Outcomes (1)
wound healing 1
1, 2 and 8 weeks
Study Arms (3)
subtarsal approach
ACTIVE COMPARATORinfraorbital approach
ACTIVE COMPARATORtransconjunctival approach
ACTIVE COMPARATORInterventions
orbital fracture reduction and fixation
Eligibility Criteria
You may qualify if:
- Patient with orbital fractures (e.g., orbital floor or zygomaticomaxillary complex fractures) require open reduction with internal fixation.
- Adult patient between 20 and 50 years with no gender predilections.
You may not qualify if:
- Existing lacerations in the inferior and lateral periorbital regions.
- Comminuted fracture with bone loss.
- Existence of infection at the fracture line.
- Presence of acute or chronic conjunctival diseases.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Alexandria university
Alexandria, Outside US and Canada, 2881055, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- lecturer
Study Record Dates
First Submitted
July 29, 2026
First Posted
August 12, 2026
Study Start
May 25, 2026
Primary Completion (Estimated)
November 25, 2026
Study Completion (Estimated)
November 25, 2026
Last Updated
August 12, 2026
Record last verified: 2026-08